Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Oct 14 (Reuters) — Estrella Immunopharma Inc: Estrella Immunopharma Activates Intermountain Health Lds Hospital As Fifth Clinical Site For Phase I/ii Starlight-1 Trial In B-cell Non-hodgkin’s Lymphoma Source text:... Further company coverage: ESLA.O (reuters.briefs@thomsonreuters.com;)
For best results when printing this announcement, please click on link below: Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) (“Estrella” or the “Company”), a clin